课题基金 / 基金详情

CORE--Molecular Resources Core

CORE--Molecular Resources Core
CORE--分子资源核心
批准号:
6967991
负责人:
Randal A Skidgel
金额:
$26.67万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-03-01 至 2010-02-28

项目摘要

项目成果

Randal A Skidgel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Core C, the Molecular Resources Core, will provide molecular reagents and services to all four projects and will be crucial to the completion of the specific aims of each proposal in the Program Project. The proposal for a Molecular Resources Core is a continuation of the original Core C. The overall function of Core C is to provide molecular reagents and expertise, including generation of deletion and site-directed mutants and incorporation into the desired expression vectors, creation of minigene constructs, generation of adenoviral and retroviral constructs for transduction of primary endothelial cells and designing and generating appropriate siRNA based constructs. This core will be directed by Dr. Randal A. Skidgel and will be staffed by a full-time Senior Research Specialist (Dr. Barbara Keith), full- time Research Specialist (TBN) and part-time Research Associate (Vidas Dumasias). Consolidating these efforts in Core C will result in increased speed and efficiency in accomplishing the research tasks outlined in each of the projects and uniformity of approaches and methods so that resutts from each project can be compared. In addition, it will allow strict quality control and consistency of molecular reagents to be used by the various projects. Furthermore, an added and important benefit of the centralized Core C will be to markedly decrease expenses compared to a scenario in which each project would generate its own molecular resources. Regular meetings of the Core leader with the Senior Research Specialist and project leaders will assure coordination and prioritization of the generation of molecular reagents and assure that the desired reagents are provided in a timely manner to the component projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a new drug for treating myocardial ischemia/reperfusion injury
  • 批准号:
    10491205
  • 项目类别:
  • 资助金额:
    $114.17万
  • 财政年份:
    2021
  • 负责人:
    Randal A Skidgel
  • 依托单位:
Developing a new drug for treating myocardial ischemia/reperfusion injury
  • 批准号:
    10325868
  • 项目类别:
  • 资助金额:
    $85.69万
  • 财政年份:
    2021
  • 负责人:
    Randal A Skidgel
  • 依托单位:
Targeting integrin outside-in signaling for treating sepsis
  • 批准号:
    10461718
  • 项目类别:
  • 资助金额:
    $63.5万
  • 财政年份:
    2018
  • 负责人:
    Randal A Skidgel
  • 依托单位:
Targeting integrin outside-in signaling for treating sepsis
  • 批准号:
    10625353
  • 项目类别:
  • 资助金额:
    $58.21万
  • 财政年份:
    2018
  • 负责人:
    Randal A Skidgel
  • 依托单位:
海外基金